Respiratory Monitoring in Neuromuscular Weakness Patients and Long-Term Management of Myasthenia Gravis

This chapter covers the importance of close respiratory monitoring for neuromuscular weakness patients with healthy lung perincoma and delves into the long-term management of myasthenia gravis, discussing various treatments, including newer medications like eculizumab and ravulizumab. It also explores the use of Vivgart and F-Gartigamod post-intravenous immunoglobulin therapy, and details the role of intravenous and subcutaneous immunoglobulin as maintenance treatments.